Amanote Research
Register
Sign In
Increased Antitumor Activity, Intratumor Paclitaxel Concentrations, and Endothelial Cell Transport of Cremophor-Free, Albumin-Bound Paclitaxel, ABI-007, Compared With Cremophor-Based Paclitaxel
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-1634
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
February 15, 2006
Authors
N. Desai
Publisher
American Association for Cancer Research (AACR)
Related search
Intraarterial Chemotherapy With Polyoxyethylated Castor Oil Free Paclitaxel, Incorporated in Albumin Nanoparticles (ABI-007)
Cancer
Cancer Research
Oncology
Albumin-Bound Paclitaxel (ABI-007; Abraxane) in the Management of Basal-Like Breast Carcinoma
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Phase I and Pharmacokinetic Study of Genexol-Pm, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients With Advanced Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Novel Free Paclitaxel-Loaded Poly(L-Γ-Glutamylglutamine)–paclitaxel Nanoparticles
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Paclitaxel Uptake and Transport in Taxus Cell Suspension Cultures
Biochemical Engineering Journal
Bioengineering
Environmental Engineering
Biomedical Engineering
Biotechnology
Repetitive Responses to Nanoparticle Albumin-Bound Paclitaxel and Carboplatin in Malignant Pleural Mesothelioma
Respirology Case Reports
Pulmonary
Respiratory Medicine
Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Targeted Delivery of Albumin Bound Paclitaxel in the Treatment of Advanced Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
SPARC Is a Possible Predictive Marker for Albumin-Bound Paclitaxel in Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
